ArticlePakistan journal of medical sciences2025
The effect of transcutaneous electrical nerve stimulation-assisted therapy combined with pregabalin in the treatment of trigeminal neuralgia.
Article in Pakistan journal of medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Transcutaneous electrical nerve stimulation (TENS) therapy has become an emerging option for acute and chronic pain. This study aimed to investigate the efficacy of TENS combined with pregabalin in treating trigeminal neuralgia (TN). Methods: Clinical records of TN patients treated with pregabalin in the Department of Pain Management, the Second Affiliated Hospital of Guangxi Medical University, from October 2022 to October 2024 were retrospectively analyzed. Patients were divided into the TENS group and the non-TENS group based on the treatment method. The pain severity, sleep quality, levels of pain-inducing factors, quality of life, and incidence of adverse reactions in the two groups were compared before and after four weeks of treatment. Results: Records of 205 patients were included in the analysis, with 104 in the TENS group and 101 in the non-TENS group. After four weeks of treatment, the visual analog scale (VAS) and The Pittsburgh Sleep Quality Index (PSQI) scores in the TENS group were significantly lower than those in the non-TENS group (all P<0.05). The levels of pain-inducing factors and improvement in quality of life in the TENS group were considerably better compared to the non-TENS group (all P<0.05). There was no significant intergroup difference in the incidence of adverse reactions (P>0.05). Conclusions: In TN patients, a combination of TENS and pregabalin was associated with higher treatment efficiency without an increase in adverse reactions compared to pregabalin monotherapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.